Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

1 Mar 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Gestational Diabetes Research and Management
Share to Ovarian function and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35236761
DOI: 10.1136/openhrt-2022-001989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetesPMID 35236761Read ↗

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.Semantic proximity Read ↗

Myo-inositol versus Metformin in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Anthropometric, Endocrine, Metabolic, and Reproductive OutcomesSemantic proximity Read ↗

Use of Inositols in Polycystic Ovary SyndromeSemantic proximity Read ↗

Inositols: From Established Knowledge to Novel ApproachesSemantic proximity Read ↗

MYPP trial: Myo-inositol supplementation to prevent pregnancy complications in women with polycystic ovary syndrome, study protocol for a multicenter, double-blind, randomized controlled trialSemantic proximity Read ↗

Myo-Inositol and Its Derivatives: Their Roles in the Challenges of InfertilitySemantic proximity Read ↗

The effect of Myo-Inositol supplement on molecular regulation of folliculogenesis, steroidogenesis, and assisted reproductive technique outcomes in patients with polycystic ovarian syndromeSemantic proximity Read ↗

Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial.Semantic proximity Read ↗

The myo-inositol effect on the oocyte quality and fertilization rate among women with polycystic ovary syndrome undergoing assisted reproductive technology cycles: a randomized clinical trialSemantic proximity Read ↗

Evaluation of Myo-Inositol as a Potential Biomarker for Depression in SchizophreniaSemantic proximity Read ↗

Metabolic Phenotype Predicts Biochemical Response to Inositol Supplementation in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Melatonin and Myo-Inositol: Supporting Reproduction from the Oocyte to BirthSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.